NCT06267664View on ClinicalTrials.gov

Real-world Effectiveness and Tolerability of Triptans-Ditans-Gepants (TRIDIGEP)

RecruitingOBSERVATIONAL
Enrollment

1,500

Participants

Timeline

Start Date

December 4, 2023

Primary Completion Date

September 30, 2024

Study Completion Date

December 1, 2024

Conditions
MigraineMigraine DisordersMigraine With AuraHeadache Disorders
Interventions
DRUG

Patients with migraine treated with triptans, Lasmiditan or Gepants

Patients will complete the study information in their smartphones, tablets or computers, using a QR code or a link that will redirect hem to the study questionnaires. RedCap will be used in the study.

Trial Locations (1)

47010

RECRUITING

Hospital Clínico Universitario de Valladolid, Valladolid

All Listed Sponsors
lead

Hospital Clínico Universitario de Valladolid

OTHER